M&A activity in the Healthcare industry remains at high levels combined with carve outs before or after the announced acquisition(s). Examples include AbbVie acquiring Allergan, BMS taking over Celgene and Pfizer spinning off Upjohn/Mylan to name a few. From an end to end supply chain perspective, M&A activity drives the need to assess the organization, processes and related infrastructure in manufacturing and distribution set up. Often a synergy target has been set to deliver day 1 and day 2 integration benefits.

In this webinar, BCI Global will address the challenges for Healthcare companies in this field and share insight in the specifics of a Merger and Acquisition situation both pre and post approval on how to deliver the benefits from M&A from an end to end supply chain perspective.

By attending you will learn:

  • The main topics that should be on the agenda in an M&A process or carve out
  • How to deliver the benefits on “ day 1”
  • Dealing deal with antitrust organizations in terms of information sharing between com-panies
  • Dealing with a cleanroom environment
  • How to identify and bank the structural day 2 benefits
  • How to make the transition and integration happen


  • 3 pm Central European Time
  • 9 am Eastern Standard Time

Speaker: Patrick Haex, Managing Partner and Martin Gouda, Partner
Duration: 60 minutes including Q&A
Costs: free of charge


Send an email with your request to attend this webinar to jeannet.kornelis@bciglobal.com. The audience for this webinar are executives/managers of manufacturing and logistics firms. BCI Global will match your request to participate with the intended audience of this webinar. In a confirmation email you will receive more information on the technical details.

Read more about Supply Chain Strategy.

For more information contact Martin Gouda, martin.gouda@bciglobal.com or call at +31-24-3790222.


Receive news from BCI